Table 1.
Characteristics of the L- and T-type VGCCs isoforms involved in cardiac automaticity.
L-type VGCC (Cav1) | T-type VGCC (Cav3) | |||
---|---|---|---|---|
Cav1.2 | Cav1.3 | Cav3.1 | Cav3.2 | |
Expression time | Embryonic stage | Embryonic stage | Start to increase in the perinatal period and becomes predominant in the adulthood | High in Embryonic heart tissue and then decrease and disappear in adult heart |
Cardiac tissues expression | SAN, AVN, atria, PF networks, Ventricles | SAN, AVN, atria, PF networks, poorly or not expressed in ventricular | SAN, AVN, atria, PF networks, poorly or not expressed in ventricular tissue | SAN, AVN, atria, PF networks, poorly expressed in ventricular tissue |
Voltage dependent activation | High threshold of activation (~−40 mV) Fast activation | Lower threshold of activation than Cav1.2 (~−55 mV) Fast activation | Lower threshold of activation (~−70 mV) Slow activation | |
Inactivation properties | Ca2+ and voltage dependent inactivation | Ca2+ and voltage dependent inactivation | Fast voltage dependent inactivation | |
DHP sensitivity | High | Lower than Cav1.2 | Low and very low | |
Role in pacemaking | Control the Ca2+ dependent upstroke phase of action potential | Diastolic pacemaker current | Diastolic pacemaker current | |
Knock-out mice phenotype | Lethal | Strong bradycardia, SAN arrhythmia, conduction system dysfunction | Mild bradycardia AV conduction disorders | No phenotype |